Literature DB >> 4364717

Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen.

R W Baldwin, M R Price, R A Robins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4364717     DOI: 10.1002/ijc.2910110304

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  26 in total

1.  Lymphocytotoxicity to tumor target cells and interference of serum factors or tumor antigen with lymphocytotoxicity in patients suffering from different stages of breast carcinoma.

Authors:  H Warnatz; D Lackner; E Eder; F Scheiffarth; M Gruhl; O Bischoff
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-02-25

2.  Tumor size, leukocyte adherence inhibition and serum levels of tumor antigen in dogs with the canine transmissible venereal sarcoma.

Authors:  T J Yang; T J Palker; M W Harding
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Inhibition of sensitized leukocyte's in vitro reactivity by circulating immune complexes in prostate cancer.

Authors:  R Bhatti; M Shaw; P Ray
Journal:  Experientia       Date:  1987-08-15

4.  Effect of splenectomy on the growth of adenovirus 12 tumors in hamsters.

Authors:  P Erb; L Baselgia; M Gasser; A Honegger; H Loeffler
Journal:  Experientia       Date:  1974-08-15

5.  Significance of tumour associated antigens on human colonic carcinomata.

Authors:  M J Embleton
Journal:  Br J Cancer Suppl       Date:  1973-08

6.  Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes.

Authors:  D R Vlock; J M Kirkwood
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

Review 7.  Suppressor mechanisms in tumor immunity.

Authors:  G T Nepom; I Hellström; K E Hellström
Journal:  Experientia       Date:  1983-03-15

8.  Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease.

Authors:  W E Brandeis; L Helson; Y Wang; R A Good; N K Day
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

9.  In vivo release of glycoprotein I from the Ha subline of TA3 murine tumor into ascites fluid and serum.

Authors:  A G Cooper; J F Codington; M C Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

10.  Induction of cell-mediated immunity to Mycobacterium lepraemurium in susceptible mice.

Authors:  M J Lefford; P J Patel; L W Poulter; G B Mackaness
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.